Taking this further, elevated TGF-β1 levels in human HCC tissue are associated with poor prognosis and immune suppression, marking it as a potential target for immunotherapy (Gough et al. 2021; Jin et al. 2022). Here, TGFB1 is linked to hepatocellular carcinoma.